Search by Drug Name or NDC

    NDC 27241-0209-30 Brexpiprazole 4 mg/1 Details

    Brexpiprazole 4 mg/1

    Brexpiprazole is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Ajanta Pharma USA Inc.. The primary component is BREXPIPRAZOLE.

    Product Information

    NDC 27241-0209
    Product ID 27241-209_430dc8c4-7349-42d5-9036-b0bdcc02a839
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Brexpiprazole
    Proprietary Name Suffix n/a
    Non-Proprietary Name Brexpiprazole
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 4
    Active Ingredient Units mg/1
    Substance Name BREXPIPRAZOLE
    Labeler Name Ajanta Pharma USA Inc.
    Pharmaceutical Class Atypical Antipsychotic [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA213718
    Listing Certified Through 2024-12-31

    Package

    NDC 27241-0209-30 (27241020930)

    NDC Package Code 27241-209-30
    Billing NDC 27241020930
    Package 30 TABLET in 1 BOTTLE (27241-209-30)
    Marketing Start Date 2023-02-03
    NDC Exclude Flag N
    Pricing Information N/A